TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 177 filers reported holding TG THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,219,273 | -64.8% | 145,846 | -36.8% | 0.00% | -66.7% |
| Q1 2023 | $3,468,254 | -60.9% | 230,602 | -89.0% | 0.01% | -63.6% |
| Q2 2022 | $8,878,000 | +267.5% | 2,088,952 | +722.3% | 0.03% | +371.4% |
| Q1 2022 | $2,416,000 | -21.4% | 254,028 | +57.1% | 0.01% | -22.2% |
| Q4 2021 | $3,072,000 | -48.2% | 161,679 | +5.8% | 0.01% | -55.0% |
| Q2 2021 | $5,928,000 | -21.3% | 152,823 | -2.2% | 0.02% | -35.5% |
| Q1 2021 | $7,531,000 | +1073.1% | 156,247 | -0.3% | 0.03% | +342.9% |
| Q4 2018 | $642,000 | – | 156,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |